Bank of America’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
Sell
-500
Closed -$37K 7627
2015
Q2
$37K Buy
+500
New +$36.1K ﹤0.01% 6086
2015
Q1
Sell
-211,700
Closed -$13.8M 7912
2014
Q4
$13.8M Buy
211,700
+207,900
+5,471% +$13.4M ﹤0.01% 1675
2014
Q3
$228K Sell
3,800
-1,400
-27% -$91.5K ﹤0.01% 5279
2014
Q2
$360K Buy
5,200
+2,000
+63% +$130K ﹤0.01% 4947
2014
Q1
$209K Sell
3,200
-1,100
-26% -$71.6K ﹤0.01% 5399
2013
Q4
$266K Sell
4,300
-3,700
-46% -$214K ﹤0.01% 5327
2013
Q3
$429K Buy
8,000
+7,400
+1,233% +$381K ﹤0.01% 4776
2013
Q2
$27K Buy
+600
New +$26K ﹤0.01% 6854

Other funds holding STJ

Bank of America's STJ Position: Q1 2017 in Review

Bank of America sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 3,004,373 shares — an estimated $241M sold.

Bank of America first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $259M in Q4 2014. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Bank of America reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Bank of America sold 3,004,373 St Jude Medical shares in Q1 2017, an estimated $241M.
  • Bank of America first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • Bank of America's St Jude Medical position peaked at $259M in Q4 2014.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Bank of America's 13F filing for Q1 2017, filed 15 May 2017.